









市場行情
/
股票
/
nasdaq-mlab
/

Mesa Laboratories Inc

MLAB

80.470USD

-0.200-0.25%

收盤 12/26, 16:00（美東）報價延遲15分鐘

443.45M總市值

虧損本益比TTM



Mesa Laboratories Inc

80.470

-0.200-0.25%

概覽公司財務分析

概覽

公司

財務

分析

關於 Mesa Laboratories Inc 公司

Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.

Mesa Laboratories Inc簡介



公司代碼MLAB

公司名稱Mesa Laboratories Inc

上市日期Feb 29, 1984

CEOOwens (Gary M)

員工數量730

證券類型Ordinary Share

年結日Feb 29

公司地址12100 W 6th Ave

城市LAKEWOOD

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編80228

電話13039878000

網址https://mesalabs.com

公司代碼MLAB

上市日期Feb 29, 1984

CEOOwens (Gary M)

Mesa Laboratories Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Gary M. Owens

President, Chief Executive Officer, Director

148.26K

+8.45%

Dr. John James Sullivan, Ph.D.

Independent Chairman of the Board

70.06K

-2.78%

Mr. John V. Sakys

Chief Financial Officer, Vice President

41.70K

+31.03%

Mr. Brian Archbold

Senior Vice President - Continuous Improvement

Mr. Shiraz S. Ladiwala

Lead Independent Director

Mr. Mark Christophe Capone

Independent Director

Ms. Jennifer S. Alltoft

Independent Director

Mr. R. Tony Tripeny

Independent Director

Ms. Shannon M. Hall

Independent Director

名稱

名稱/職務

職務

持股

持股變動

Mr. Gary M. Owens

President, Chief Executive Officer, Director

148.26K

+8.45%

Dr. John James Sullivan, Ph.D.

Independent Chairman of the Board

70.06K

-2.78%

Mr. John V. Sakys

Chief Financial Officer, Vice President

41.70K

+31.03%

Mr. Brian Archbold

Senior Vice President - Continuous Improvement

Mr. Shiraz S. Ladiwala

Lead Independent Director

Mr. Mark Christophe Capone

Independent Director

收入明細

單位: USD更新時間: 10月6日週一

FY2026Q1

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Discrete Revenues- Consumables

35.77M

60.08%

Discrete Revenues- Hardware and Software

12.57M

21.11%

Contracted Revenues- Services

7.90M

13.26%

Discrete Revenues- Services

3.31M

5.55%

地區USD

名稱

營收

佔比

United States

27.65M

46.43%

Other

26.47M

44.45%

China

5.43M

9.12%

業務

地區

業務USD

名稱

營收

佔比

Discrete Revenues- Consumables

35.77M

60.08%

Discrete Revenues- Hardware and Software

12.57M

21.11%

Contracted Revenues- Services

7.90M

13.26%

Discrete Revenues- Services

3.31M

5.55%

股東統計

更新時間: 11月16日週日

持股股東

股東類型

持股股東

佔比

Conestoga Capital Advisors, LLC

7.72%

BlackRock Institutional Trust Company, N.A.

5.93%

The Vanguard Group, Inc.

5.83%

Ranger Investment Management, L.P.

3.80%

Geneva Capital Management LLC

3.47%

其他

73.26%

持股股東

佔比

Conestoga Capital Advisors, LLC

7.72%

BlackRock Institutional Trust Company, N.A.

5.93%

The Vanguard Group, Inc.

5.83%

Ranger Investment Management, L.P.

3.80%

Geneva Capital Management LLC

3.47%

其他

73.26%

股東類型

持股股東

佔比

Investment Advisor

37.82%

Investment Advisor/Hedge Fund

35.41%

Hedge Fund

13.57%

Individual Investor

5.44%

Research Firm

4.14%

Bank and Trust

0.88%

Pension Fund

0.84%

Sovereign Wealth Fund

0.06%

Insurance Company

0.03%

其他

1.82%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

387

5.12M

92.75%

-722.23K

2025Q2

399

5.60M

101.85%

-541.53K

2025Q1

415

5.83M

106.86%

-307.02K

2024Q4

405

5.76M

105.94%

-86.00K

2024Q3

413

5.30M

97.90%

-538.92K

2024Q2

412

5.31M

98.26%

-376.30K

2024Q1

404

5.28M

97.81%

-366.78K

2023Q4

400

5.27M

97.82%

-295.14K

2023Q3

392

5.33M

99.02%

-178.63K

2023Q2

390

5.31M

98.92%

-355.72K

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Conestoga Capital Advisors, LLC

566.15K

10.29%

-5.21K

-0.91%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

708.66K

12.88%

-30.52K

-4.13%

Jun 30, 2025

The Vanguard Group, Inc.

388.10K

7.05%

+4.80K

+1.25%

Jun 30, 2025

Ranger Investment Management, L.P.

214.29K

3.9%

-16.70K

-7.23%

Jun 30, 2025

Geneva Capital Management LLC

199.09K

3.62%

+9.78K

+5.17%

Jun 30, 2025

Royce Investment Partners

247.61K

4.5%

-23.51K

-8.67%

Jun 30, 2025

Owens (Gary M)

136.70K

2.48%

+13.43K

+10.89%

Jun 21, 2025

Janus Henderson Investors

113.28K

2.06%

+32.54K

+40.30%

Jun 30, 2025

Atlanta Capital Management Company, L.L.C.

145.94K

2.65%

-1.85K

-1.25%

Jun 30, 2025

持股ETF



更新時間: 12月2日週二

機構名稱

佔比

VictoryShares Small Cap Free Cash Flow ETF

0.22%

Principal U.S. Small-Cap ETF

0.1%

Vanguard US Quality Factor ETF

0.09%

SPDR SSGA US Small Cap Low Volatility Index ETF

0.08%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.06%

WisdomTree US SmallCap Fund

0.05%

Avantis US Small Cap Equity ETF

0.05%

WisdomTree U.S. SmallCap Dividend Fund

0.05%

Invesco Russell 2000 Dynamic Multifactor ETF

0.02%

iShares Russell 2000 Growth ETF

0.02%

VictoryShares Small Cap Free Cash Flow ETF

佔比0.22%

Principal U.S. Small-Cap ETF

佔比0.1%

Vanguard US Quality Factor ETF

佔比0.09%

SPDR SSGA US Small Cap Low Volatility Index ETF

佔比0.08%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

佔比0.06%

WisdomTree US SmallCap Fund

佔比0.05%

Avantis US Small Cap Equity ETF

佔比0.05%

WisdomTree U.S. SmallCap Dividend Fund

佔比0.05%

Invesco Russell 2000 Dynamic Multifactor ETF

佔比0.02%

iShares Russell 2000 Growth ETF

佔比0.02%

分紅派息



近5年累計派現 16.82M 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

Oct 03, 2025

MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Dec 15, 2025 going ex on Nov 28, 2025

Nov 28, 2025

Dec 15, 2025

Nov 28, 2025

Jul 03, 2025

MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 15, 2025 going ex on Aug 29, 2025

Aug 29, 2025

Sep 15, 2025

Aug 29, 2025

Apr 07, 2025

MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Jun 16, 2025 going ex on May 30, 2025

May 30, 2025

Jun 16, 2025

May 30, 2025

Jan 08, 2025

MLAB.NB Final Cash Dividend of gross USD 0.16 paid on Mar 17, 2025 going ex on Feb 28, 2025

Feb 28, 2025

Mar 17, 2025

Feb 28, 2025

Oct 02, 2024

MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Dec 16, 2024 going ex on Nov 29, 2024

Nov 29, 2024

Dec 16, 2024

Nov 29, 2024

Jul 10, 2024

MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 16, 2024 going ex on Aug 30, 2024

Aug 30, 2024

Sep 16, 2024

Aug 30, 2024

Apr 05, 2024

MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Jun 14, 2024 going ex on May 31, 2024

May 31, 2024

Jun 14, 2024

May 31, 2024

Jan 04, 2024

MLAB.NB Final Cash Dividend of gross USD 0.16 paid on Mar 15, 2024 going ex on Feb 28, 2024

Feb 29, 2024

Mar 15, 2024

Feb 28, 2024

Oct 03, 2023

MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Dec 15, 2023 going ex on Nov 29, 2023

Nov 30, 2023

Dec 15, 2023

Nov 29, 2023

Jul 05, 2023

MLAB.NB Interim Cash Dividend of gross USD 0.16 paid on Sep 15, 2023 going ex on Aug 30, 2023

Aug 31, 2023

Sep 15, 2023

Aug 30, 2023

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

Mesa Laboratories Inc的前五大股東是誰？



Mesa Laboratories Inc的前五大股東如下：
Conestoga Capital Advisors, LLC
持有股份：566.15K
佔總股份比例：10.29%。
BlackRock Institutional Trust Company, N.A.
持有股份：708.66K
佔總股份比例：12.88%。
The Vanguard Group, Inc.
持有股份：388.10K
佔總股份比例：7.05%。
Ranger Investment Management, L.P.
持有股份：214.29K
佔總股份比例：3.90%。
Geneva Capital Management LLC
持有股份：199.09K
佔總股份比例：3.62%。